Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ACETAZOLAMIDE TABLE

Closed
SPE2DP-26-T-3461Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This contract covers the procurement of Acetazolamide tablets, USP, with each tablet containing 250 mg of the active ingredient. The tablets are packaged in bottles containing 100 tablets each, with a required minimum remaining shelf life of 31 months upon receipt by the government. The total shelf life is 36 months, and the product must be stored within controlled room temperatures between 20° to 25°C, with allowable excursions from 15° to 30°C. Packaging must meet DLA’s commercial standards, ensuring proper sealing and protection against damage during shipment. All labeling and marking must conform to Medical Marking Standard No. 1A, superseding older military standards, to assure regulatory compliance and facilitate tracking. The contract stipulates that shipments are to be delivered to the destination within 20 days, with inspection and acceptance also occurring at that point. It incorporates adherence to specific technical and quality requirements listed in the DLA Master List, aligning with regulatory rules including FDA oversight. Removal of government identification is mandated for any non-accepted supplies. Several manufacturers and suppliers are identified for this product, and the contract is issued under a specific solicitation number, managed by the Department of Defense Medical Supply Chain with a designated point of contact. The procurement adheres strictly to defined quantities and packaging data requirements, ensuring compliance with all federal acquisition and medical standards.

General Info

Procurement of 250mg Acetazolamide tablets, 100 per bottle, 31-month shelf life, FDA compliant.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3461 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS

Full Description

Show more
ACETAZOLAMIDE TABLE
ACETAZOLAMIDE TABLETS,USP.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RX ONLY, ORAL ADMINISTRATION
.
EACH TABLET CONTAINS 250 MILLIGRAMS (MG) OF
ACETAZOLAMIDE, USP AS THE ACTIVE INGREDIENT
.
UNIT OF ISSUE IS A BOTTLE (BT) CONTAINING 100 TABLETS (TT)
.
TOTAL SHELF LIFE IS 36 MONTHS.
SPE2DP-26-T-3461
SECTION B
.
THERE SHALL BE A MINIMUM OF 31 MONTHS OF REMAINING SHELF LIFE
AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 20° TO 25°C (68° TO 77°F) EXCURSIONS PERMITTED
BETWEEN 15 AND 30°C (59 TO 86°F)
[SEE USP CONTROLLED ROOM TEMPERATURE]
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
6/22/2016
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
1 BT = 100 TT RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135-0567-01 AVKARE LLC 4QGW8 P/N NDC42291-0090-01 TARO PHARMACEUTICALS U.S.A., INC. 3HFB6 P/N NDC51672-4023-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0034-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016814925 0001 BT 1.000
NSN/MATERIAL:6505006640857
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-664-0857 Quantity: 1 BT Purchase Request: 7016814925QTY: 1 Delivery: 20 days ADO